Search Count: 12
![]() |
Solution Structure Of The Yeast Ddi1 Hdd Domain
Organism: Saccharomyces cerevisiae
Method: SOLUTION NMR Release Date: 2016-10-05 Classification: UNKNOWN FUNCTION |
Organism: Saccharomyces cerevisiae
Method: SOLUTION NMR
Release Date: 2016-10-05
![]() |
Hdd Domain From Human Ddi2
|
Organism: Homo sapiens
Method: SOLUTION NMR
Release Date: 2016-08-10
![]() |
Solution Structure Of The Ubl Domain Of Human Ddi2
Organism: Homo sapiens
Method: SOLUTION NMR Release Date: 2016-07-20 Classification: UNKNOWN FUNCTION |
Organism: Homo sapiens
Method: SOLUTION NMR
Release Date: 2016-07-20
![]() |
Solution Structure Of The Ubl Domain Of Yeast Ddi1
Organism: Saccharomyces cerevisiae
Method: SOLUTION NMR Release Date: 2016-07-20 Classification: UNKNOWN FUNCTION |
Organism: Saccharomyces cerevisiae
Method: SOLUTION NMR
Release Date: 2016-07-20
![]() |
New Crystal Structure Of Yeast Ddi1 Aspartyl Protease Reveals Substrate Engagement Mode
Organism: Saccharomyces cerevisiae
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2016-04-13 Classification: HYDROLASE |
Organism: Saccharomyces cerevisiae
Method: X-RAY DIFFRACTION
Release Date: 2016-04-13
![]() |
Structure Of Hiv Pr Resistant Patient Derived Mutant (Comprising 22 Mutations) In Complex With Drv
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2012-06-20 Classification: HYDROLASE Ligands: 017, BME, SO4 |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION
Release Date: 2012-06-20
Ligands: 017, BME, SO4
![]() |
Hiv Pr Drug Resistant Patient'S Variant In Complex With Darunavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2012-01-18 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 017, BME |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2012-01-18
Ligands: 017, BME
![]() |
Hiv Pr Drug Resistant Patient'S Variant In Complex With Darunavir
Organism: Human immunodeficiency virus type 1 (bru isolate)
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2009-08-11 Classification: HYDROLASE Ligands: 017 |
Organism: Human immunodeficiency virus type 1 (bru isolate)
Method: X-RAY DIFFRACTION
Release Date: 2009-08-11
Ligands: 017
![]() |
Hiv-1 Pr Resistant Mutant + Lpv
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2008-08-05 Classification: HYDROLASE Ligands: SO4, AB1, GOL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2008-08-05
Ligands: SO4, AB1, GOL
![]() |
Hiv-1 Pr Resistant Mutant + Lpv
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2008-08-05 Classification: HYDROLASE Ligands: GOL, AB1 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2008-08-05
Ligands: GOL, AB1
![]() |
The Influence Of I47A Mutation On Reduced Susceptibility To The Protease Inhibitor Lopinavir
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.80 Å Release Date: 2008-07-22 Classification: HYDROLASE Ligands: BME, AB1 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2008-07-22
Ligands: BME, AB1
![]() |
The Influence Of I47A Mutation On Reduced Susceptibility To The Protease Inhibitor Lopinavir
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION Resolution:2.31 Å Release Date: 2008-07-01 Classification: HYDROLASE Ligands: BME, AB1 |
Organism: Human immunodeficiency virus type 1
Method: X-RAY DIFFRACTION
Release Date: 2008-07-01
Ligands: BME, AB1
